Maryland 2026 Session Status: Introduced 3 D cosponsors

HB1440 — Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board

Last action — Committee Report (House of Origin) — Withdrawn

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House of Delegates
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House of Delegates. Introduced February 13, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Prohibiting a managed care organization and certain insurers, nonprofit health service plans, and health maintenance organizations from requiring a prior authorization or step therapy or fail-first protocol under certain circumstances for prescription drugs that have been reviewed by the Prescription Drug Affordability Board; etc.

Bill Text

We don't have the full text on file for this bill yet.

Read HB1440 on the official Maryland source →

Action History

  1. Committee Report (House of Origin) — Withdrawn

  2. First Reading (House of Origin)

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 2 co-sponsors · 185 not signed on

Sponsors (1)

Co-sponsors (2)

Not signed on (185)

185 members have not signed on to this bill.

Show all 185 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB1440 do?
Prohibiting a managed care organization and certain insurers, nonprofit health service plans, and health maintenance organizations from requiring a prior authorization or step therapy or fail-first protocol under certain circumstances for prescription drugs that have been reviewed by the Prescription Drug Affordability Board; etc.
Who sponsors HB1440?
HB1440 is sponsored by Delegate Teresa Woorman (Democrat), Delegate Aaron M. Kaufman (Democrat), and Delegate Ashanti Martinez (Democrat).
What is the current status of HB1440?
This bill has been introduced in the House of Delegates. Introduced February 13, 2026. It must pass committee before a floor vote.
Where can I track HB1440?
Track HB1440 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB1440

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB1440

Last checked for changes 1 day ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →